You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Seroquel XR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Seroquel Xr, and when can generic versions of Seroquel Xr launch?

Seroquel Xr is a drug marketed by Astrazeneca and is included in one NDA.

The generic ingredient in SEROQUEL XR is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Seroquel Xr

A generic version of Seroquel XR was approved as quetiapine fumarate by ACCORD HLTHCARE on March 27th, 2012.

  Try a Trial

Drug patent expirations by year for Seroquel XR
Drug Prices for Seroquel XR

See drug prices for Seroquel XR

Drug Sales Revenue Trends for Seroquel XR

See drug sales revenues for Seroquel XR

Recent Clinical Trials for Seroquel XR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ain Shams UniversityN/A
University of MiamiPhase 4
Alzheimer's AssociationPhase 4

See all Seroquel XR clinical trials

Pharmacology for Seroquel XR
Anatomical Therapeutic Chemical (ATC) Classes for Seroquel XR
Paragraph IV (Patent) Challenges for SEROQUEL XR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
SEROQUEL XR Extended-release Tablets quetiapine fumarate 150 mg 022047 1 2008-11-17
SEROQUEL XR Extended-release Tablets quetiapine fumarate 50 mg 022047 1 2008-10-17
SEROQUEL XR Extended-release Tablets quetiapine fumarate 400 mg 022047 1 2008-06-18
SEROQUEL XR Extended-release Tablets quetiapine fumarate 200 mg and 300 mg 022047 1 2008-06-12

US Patents and Regulatory Information for Seroquel XR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca SEROQUEL XR quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 022047-001 May 17, 2007 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Astrazeneca SEROQUEL XR quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 022047-003 May 17, 2007 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Astrazeneca SEROQUEL XR quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 022047-005 Aug 11, 2008 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Seroquel XR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca SEROQUEL XR quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 022047-001 May 17, 2007 ⤷  Try a Trial ⤷  Try a Trial
Astrazeneca SEROQUEL XR quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 022047-004 May 17, 2007 ⤷  Try a Trial ⤷  Try a Trial
Astrazeneca SEROQUEL XR quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 022047-002 May 17, 2007 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for Seroquel XR

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0240228 2000C/015 Belgium ⤷  Try a Trial PRODUCT NAME: QUETIAPINE FUMARAT (EQUIV. MET 25MG QUETIAPINE BASE); REGISTRATION NO/DATE: 624 S 309 F 3 20000207; FIRST REGISTRATION: GB PL 12619/0113 19970731
0240228 9/2000 Austria ⤷  Try a Trial PRODUCT NAME: QUETIAPIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ZULAESSIGEN SALZES; NAT. REGISTRATION NO/DATE: 1-23460, 1-23461 1-23463 20000113; FIRST REGISTRATION: GB 12619/0112 - 12619/0114 19970731
0240228 SPC/GB97/086 United Kingdom ⤷  Try a Trial PRODUCT NAME: QUETIAPINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY-ACCEPTABLE SALT; REGISTERED: UK 12619/0112 19970731; UK 12619/0113 19970731; UK 12619/0114 19970731
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.